Sale!

COL2A1 Gene Osteoarthritis with Mild Chondrodysplasia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “COL2A1 Gene Osteoarthritis with Mild Chondrodysplasia Genetic Test” is a specialized diagnostic tool offered at DNA Labs UAE, designed to identify mutations in the COL2A1 gene. This gene plays a crucial role in the production of type II collagen, a major component of cartilage tissue. Mutations in the COL2A1 gene are associated with various skeletal disorders, including osteoarthritis and mild chondrodysplasia, conditions characterized by joint pain and cartilage abnormalities, respectively.

Osteoarthritis is a common degenerative joint disease that leads to the breakdown of joint cartilage and underlying bone, causing pain and stiffness, primarily in the hands, knees, hips, and spine. On the other hand, chondrodysplasia refers to a group of disorders characterized by the abnormal development of cartilage and bone, leading to skeletal and growth abnormalities.

The test available at DNA Labs UAE aims to provide individuals with precise genetic information regarding the COL2A1 gene, enabling early detection and the possibility of personalized management strategies for those affected by or at risk of developing these conditions. This proactive approach can significantly impact the quality of life of individuals with a predisposition to osteoarthritis and chondrodysplasia by allowing for early interventions.

Priced at 4400 AED, the test is conducted in a state-of-the-art facility equipped with the latest in genetic testing technology, ensuring accurate and reliable results. DNA Labs UAE is committed to providing comprehensive support and guidance throughout the testing process, from sample collection to result interpretation, helping individuals understand their genetic health and take informed steps towards managing their condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test

Welcome to DNA Labs UAE, a leading genetic laboratory offering the COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test. This test helps diagnose and identify mutations in the COL2A1 gene that may be causing osteoarthritis with mild chondrodysplasia.

Test Details

The COL2A1 gene is responsible for producing a protein called type II collagen, which is a major component of cartilage in the body. Mutations in this gene can lead to various disorders, including osteoarthritis with mild chondrodysplasia. Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage and the formation of bone spurs. Chondrodysplasia refers to a group of genetic disorders that affect the development and growth of cartilage and bone.

Our COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously. This allows us to identify mutations or variants in the COL2A1 gene that may be associated with the condition. The test is performed in our Genetics department by our qualified healthcare professionals.

Test Components and Price

The price for the COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test is 4400.0 AED. The test requires either a blood sample, extracted DNA, or one drop of blood on an FTA card. Our laboratory uses NGS technology to analyze the sample and generate the test results.

Report Delivery

The report for the COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test is typically delivered within 3 to 4 weeks. Our team works diligently to ensure accurate and timely delivery of the test results.

Pre Test Information

Prior to undergoing the COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by the condition. This information helps our healthcare professionals in interpreting the test results and providing appropriate guidance and support.

Benefits of Genetic Testing

The COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test offers valuable information for diagnosis, prognosis, and potential treatment options for individuals with osteoarthritis and chondrodysplasia. It can also help identify individuals who may be at risk of developing these conditions, allowing for early intervention and management.

It is important to note that genetic testing should always be performed and interpreted by a qualified healthcare professional or genetic counselor. They can provide the necessary guidance and support based on the test results.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Contact us today to learn more about the COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test and how it can benefit you or your loved ones.

Test Name COL2A1 Gene Osteoarthritis with mild chondrodysplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COL2A1 Gene Osteoarthritis with mild chondrodysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL2A1 Gene Osteoarthritis with mild chondrodysplasia NGS Genetic DNA Test gene COL2A1
Test Details

The COL2A1 gene is responsible for producing a protein called type II collagen, which is a major component of cartilage in the body. Mutations in this gene can lead to various disorders, including osteoarthritis with mild chondrodysplasia.

Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage and the formation of bone spurs. Chondrodysplasia refers to a group of genetic disorders that affect the development and growth of cartilage and bone.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variants that may be associated with a particular condition. In the case of osteoarthritis with mild chondrodysplasia, NGS genetic testing can help identify mutations in the COL2A1 gene that may be causing the condition.

This type of genetic testing can provide valuable information for diagnosis, prognosis, and potential treatment options for individuals with osteoarthritis and chondrodysplasia. It can also help identify individuals who may be at risk of developing these conditions, allowing for early intervention and management.

It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional or genetic counselor who can provide appropriate guidance and support based on the results.